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Objective: To isolate and carry out phenotypic characterization Candida species from clinical sources in Nairobi- 
Kenya.  
Study design/setting: Laboratory Based Experiment at Mycology Laboratory, Kenya Medical Research Institute, 
Nairobi, Kenya. We studied 130 Candida s species isolated between 2000 - 2005. The isolates were from blood, 
stool, urine, CSF and swabs of patients from different health Institutions in Nairobi.  
Methods:  Preliminary identification was done using morphological features and CHROMagar and confirmed 
using Analytical profile index (API 20 C aux).  
Results: Candida albicans were 130/150 (86.7%) whereas 13.3% were non albicans Candida and included; C. 
parapsilosis 4%, C. tropicalis 2.7%, C. krusei 2.7%, C. guilliemondii 1.3%  and C. famata, 1.3%. Germ tube positive 
C. albicans were 96.1% while only 3.8% were germ tube negative. All the 130 isolates identified as C. albicans 
formed chlamydospores on Corn meal agar and all grew at both 37 0C and 45 °C ruling out the possibility of 
Candida dubliniensis. 
Conclusion: Non albicans candida are of clinical significance and may warrant the need speciate Candida species 
from clinical setting and constantly monitor for fungal resistance as some Candida species are intrinsically 
resistant to certain antifungal drugs especially in the context of opportunistic infections in HIV/AIDS. 
                                                                   
                                                                       [Afr J Health Sci. 2011; 19:19-23]
Introduction
Candida albicans is one of the most frequently isolated 
yeasts in clinical laboratories and indeed studies have 
shown it accounts up to 80% of the yeasts recovered 
from sites of infection (1). Isolation of C. albicans has 
been associated with infections, as well as colonization, 
in both immunocompromised and immunocomptent 
patients (2). The ability of C. albicans to produce germ 
tubes and chlamydospores is the basis of its preliminary 
identification. However C. dubliniensis has recently 
been described that is very similar to C. albicans in 
many characteristics, especially germ tube formation 
and chlamydospore production (3- 6). 
Since C. albicans share these characteristics, it is likely 
that some C. dubliniensis isolates have been and will 
continue to be identified in clinical laboratory as C. 
albicans. Notably, C. dubliniensis is resistant to 
fluconazole and more virulent than C. albicans 
necessitating its differentiation.   Due to HIV/AIDS, 
other Candida species other than C. albicans have also 
emerged as significant opportunistic fungal pathogens 
(7-9).The diversity and spectrum of Candida species of 
clinical significance means there is need to develop fast 
and cost effective methods of identification. 
CHROMagar Candida technique has been used and has 
been useful in discriminating different Candida species 
as well as mixed infestations. It is a reliable and 
sensitive method for presumptive identification of more 
commonly isolated yeast species of the genus Candida 
(3-5). Rapid identification and speciation of Candida 
species is essential in clinical laboratories. However, no 
single phenotypic test is highly effective in identifying 
Candida species and combination of tests is sometimes 
necessary for identification. Molecular techniques have 
been employed to characterize Candida spp. Although 
sensitive and specific it is not cost effective for routine 
clinical mycology laboratories in resource constrained 
setup (6). The aim of the study was therefore to 
characterize Candida species from clinical sources using 
various phenotypic methods such as Gtt, Chlamydospore 
production, ChromAgar and thermotolerance. 




Materials and Methods 
Sources of isolates: A total of 150 isolates of Candida 
species recovered from blood, sputum, swabs, urine and 
catheter tips isolated between 2000 - 2005 were used. 
The isolates were culture collections at Mycology 
Laboratory, Kenya Medical Research Institute from 
various health Institutions in Nairobi, Kenya. Growth on 
Sabouraud Dextrose Agar (SDA): Primary isolation 
from stock cultures was done using SDA (Oxoid LTD 
Basingstoke, Hampshire, England,).  The SDA media 
was prepared according to manufacturers instructions. 
The sub-cultures on SDA were incubated at 37 °C for 24 
- 72 hours before observation and subsequent tests 
carried out. 
Germ tube test: This used as a presumptive test for 
identification of Candida albicans. The procedure was 
carried out as follows; a small inoculum of the test yeast 
cells from a pure culture was suspended in 0.5 ml horse 
serum. The suspension was incubated at 37 °C for 
exactly three hours after which a drop of the incubated 
serum was placed on a microscope slide and covered 
with a cover slip. The wet mounts were examined for 
presence of germ tubes using the 40 X objective. The 
isolates were classified as either germ tube positive or 
germ tube negative.  
Temperature tolerance- The isolates were cultured into 
SDA and incubated at 45 °C ambient air for 72 hours 
after which they were observed for any growth. 
CHROMagar (CHROMagarTM Candida, Paris, France) 
was used for presumptive identification of different 
Candida species and detect any mixed colonies. The 
method is based on the differential release of 
chromogenic breakdown products from products from 
various substrates following differential exoenzyme 
activity. CHROMagar was purchased as powdered 
media and the plates were prepared according to the 
manufacturers' instructions. Using an inoculating needle, 
a single colony from a pure culture was seeded into 
CHROMagar media and incubated at 35 °C for 48 hours 
after which color changes were noted.  
Chlamydospore production: Chlamydospore 
production on Corn Meal Agar (CMA) was used as a 
presumptive confirmatory test for the identification of 
Candida albicans. Briefly 17 g of Corn Meal Agar 
(CMA) (Sigma Biomed inc. France) incooperated with 
tween 80 was prepared according to the manufacturers 
instructions. To determine the isolates ability to produce 
chlamydospore, test strains were inoculated on CMA 
plates by slide culture technique. The test involved 
streaking and stabbing the media with a 48 hour old 
yeast colony and, covered with sterile cover slip and 
incubated at 25 °C for 72 hours. Chlamydospore 
production was examined after staining with lactophenol 
cotton blue. The isolates were categorized as 
chlamydospore positive or negative. Analytical Profile 
Index:  All the isolates were subjected to confirmation 
using Analytical profile index (API 20 C aux). The 





Candida albicans were isolated from swabs (37.3%), 
urine (33.3%), sputum (16.7%), aspirates (8%) and 
blood (4.7 %). All the Candida isolates showed growth 
on Saboraud Dextrose agar (SDA). Colonies were white 
to cream colored, smooth, glabrous and yeast-like in 
appearance. Microscopic morphology showed spherical 
to sub spherical budding yeast cells or blastoconidia.  
Out of the 150 isolates 130/150 (86.7%) yielded several 
shades of green colonies on CHROMagar Candida 
suggestive of C. albicans (Fig. 1b). Only 4/150 (2.7%) 
of the isolates developed a distinctive dark blue color on 
CA typical of C. tropicalis (Fig.1a). 4 % of the isolates 
developed a pink color suggestive of C. parapsilosis 
(Fig. 1c). Other Candida species gave colonies with 
colors as described in Table 1. Germ tube test indicated 
that 112/130 (86.1%) of the C. albicans were germ tube 
positive (Figure 2) and 18/130 (13.9%) were germ tube 
negative.  
C. albicans produced abundant chlamydospores and 
pseudohyphae with clusters of spores (Figure 3) on 
CMA. C. tropicalis formed blastoconidia singly and 
long pseudohyphae on CMA. C. parapsilosis formed 
blastoconidia along curved pseudohyphae and giant 
mycelial cells. C. guilliemondii formed fairly short, fine 
pseudohyphae and clusters of blastoconidia at septa. C. 
krusei formed pseudohyphae with cross-matchsticks or 
tree-like blastoconidia. C. glabrata did not form any 
pseudohyphae but small, oval, single terminal budding, 
non encapsulated yeast cells. All the C. albicans were 
















Number of Isolates (%) 
 
Colors Observed 
C. albicans 130 (86.9) Green. 
C. parapsilosis 6    (4.0) Pink 
C. tropicalis 4    (2.7) Dark blue 
C. krusei 4    (2.7)  Whitish Pink 
C. guilliemondii 2    (2.7) Pinkish Purple 
C. glabrata 2    (1.3)  light Pinkish 
C. famata 2    (1.3) White, Light Pink 
Total 150  (100)  
 










Fig. 1  Different Candida species on CHROMagar Candida after incubation at 35 °C for 48 hours. Note: a) Candida 
tropicalis- blue (b) Candida albicans- green  c) Candida parapsilosis-pink  
 
 
Fig. 2.Germ tubes positive C. albicans afte          Fig 3.Candida albicans with abundant chlamydospores on Corn Meal 
Agar                                                                         incubation for 3 hours at 37°C on Horse Serum  
 
Discussion 
In the recent years the number of serious opportunistic 
yeast infections, particularly in immunocompromised 
patients has increased significantly (7). Candida 
species accounts for over 80% of such infections. This 
study investigated a total of one hundred and fifty 
Candida isolates from clinical sources in Nairobi. 
Isolates were recovered from swabs, urine, sputum, 
aspirates, Cerebral Spinal Fluid (CSF), and blood. 
Majority of the isolates were from swabs especially 
vaginal and throat swabs, most of the specimens were 
from females, an indication that vaginal candidiasis is 
common. Very few isolates were obtained from blood 
and CSF probably because these are normally sterile 
Chlamydospore 




body fluids and candidaemia and Candida meningitis is 
not commonly reported and carry grave prognosis (8). 
C. albicans was the most frequently isolated yeast 
pathogen accounting for 86.8 % of the isolates. This is 
in line with previous investigations where C. albicans 
accounted for up to 80 % of the candidiasis infection 
(9). The figure is slightly higher than that reported 
probably due the HIV/AIDS pandemic that could 
predispose more individual to fungal infestation. 
Nevertheless, for ethical reasons we could not link the 
patients HIV status with our findings.   Although C. 
albicans was the most frequently isolated yeast 
pathogen, other Candida species were identified. These 
species included C. glabrata, C. krusei, C. parapsilosis, 
C. famata, C. guilliermondii and C. tropicalis. Previous 
studies have reported other non albicans Candida as 
emerging significant pathogens (10-11). Some Candida 
species are more virulent and intrinsically resistant to 
commonly available antifungal drug and C. tropicalis is 
one of them. 
The ability to easily differentiate between C. albicans 
and other Candida species in routine laboratory 
practice remains a technical problem. Various studies 
have described the yeast C.  dubliniensis as a 
worldwide opportunistic pathogen which is 
phylogenetically closely related to C. albicans (12-13). 
Evidence for the inducible stable fluconazole resistance 
in vitro in C. dubliensis strain have been demonstrated 
in immunocompromised patients receiving long term 
fluconazole prophylaxis (14-15). This situation has 
necessitated that clinical laboratories be able to isolate 
and discriminate yeasts of medical importance rapidly 
and as accurately as possible. 
The detection and identification of microorganisms 
depend on the availability of easy to perform screening 
and cost- effective methods. The medium most widely 
used for the isolation of Candida and other yeast 
species from clinical specimens is Sabouraud Dextrose 
Agar (SDA, 16). This is a general – purpose medium 
that supports the growth of most pathogenic fungi.  
However SDA is not a differential medium and 
colonies of different pathogenic yeast species grown on 
this agar cannot be easily distinguished from each 
other. Even careful observers are often unable to 
recognize mixtures of different yeast species when they 
occur on a single clinical specimen on SDA. Therefore, 
there is no guarantee that mixed yeast cultures will be 
detected. 
To be of value for routine isolation and presumptive 
differentiation of yeasts, an indicator medium should 
exhibit several properties. It should support the growth 
of yeasts but not of bacteria. If the medium also 
facilitates the growth of filamentous fungi, that is not 
necessarily a disadvantage, since for many clinical 
samples it is not possible to predict whether yeast or 
filamentous fungi is likely to be isolated. The 
differential property of the medium should also allow 
unambiguous presumptive discrimination between the 
yeast species most commonly encountered in clinical 
samples.  Finally it should facilitate the recognition of 
specimens containing mixtures of yeast species, and 
exposure of the fungi to the differential indicator 
substances should not affect their viabilities for 
subsequent subculture. CHROMagar Candida appears 
to fulfill all these requirements. 
Since C. albicans is the yeast species most often 
isolated from clinical material, most clinical 
laboratories approach yeast identification by applying 
simple rapid tests such as germ tube formation to 
distinguish C. albicans from other species which 
require more extensive testing for proper identification. 
However newly described yeast, C. dubliniensis is very 
similar to C. albicans in many characteristics like germ 
tube formation and chlamydospore production (17). It 
is therefore likely that C. dubliensis strains have been 
and will continue to be identified in the clinical 
laboratory as C. albicans. 
Several methods for identification of C. dubliniensis 
and discrimination from C. albicans have been 
reported. They include formation of dark green 
colonies on CHROMagar Candida (17-18), no or 
strictly reduced growth at 45oC and lack of ability to 
assimilate xylose (19). In our investigation, no C. 
dubliniensis was isolated, all the C. albicans isolates 
grew at both 37o C and 45 o C and chlamydospores were 
not typical of C. dubliniensis. 
Out of 130 C. albicans species, 3.9 % were germ tube 
negative. This is in accord with other reports that up to 
5 % of Candida albicans are germ tube negative (8). 
All the C. albicans were positive for chlamydospores 
typical of C. albicans. They all showed distinct growth 
at 37 oC and 45 oC temperatures. The non albicans 
Candida did not form any Chlamydospores and API C 
AUX 20 confirmed that they were non albicans 
Candida. 
Although Candida albicans is still the most significant 
clinically, other non albicans Candida are emerging 
significant pathogens and warrant routine 
discrimination in clinical laboratories. Candida 
dubliensis was not isolated in this study however it 
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